By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



18375 Ventura Boulevard

Tarzana  California  91356  U.S.A.
Phone: 800-417-1886 Fax: 818-990-3798



Company News
BioAlliance Strengthens the Protection of Livatag(R) (doxorubicin Transdrug(TM) with the Grant of a European Patent 7/12/2011 9:34:07 AM
Board Evolution at BioAlliance to Support Its Growth Strategy 5/23/2011 10:26:42 AM
Board Evolution at BioAlliance to Support Its Growth Strategy 5/20/2011 10:54:32 AM
BioAlliance Expands its Loramyc(R) Franchise in Japan with Sosei Co., Ltd. in a Deal Valued up to $18.5 Million 5/11/2011 6:43:57 AM
BioAlliance: Consolidated Accounts for the First Semester of 2010 8/25/2010 11:40:56 AM
BioAlliance Receives 6.4 Million Euro in Funding 3/16/2009 1:23:04 PM
BioAlliance Announces the Grant of its Main Patent on the Lauriad(R) Technology in Europe 8/22/2008 9:44:26 AM
BioAlliance Expands LoramycTM Franchise by Signing a South East Asia Deal Worth up to $12M 3/31/2008 12:10:36 PM
BioAlliance Receives Market Approval for Loramyc(R) in Germany, Belgium and Luxemburg 3/26/2008 1:25:11 PM
Immtech Pharmaceuticals, Inc. and BioAlliance Sign Licensing Agreement for Pafuramidine 12/5/2007 7:20:45 AM